About: Saratoga Opthalmology

A novel predictive scoring system aims to help quantify the risk of failure of plaque brachytherapy, a common treatment option for posterior uveal melanoma. Source: AAO

• Posted on: Mar 28 2023
• By: Saratoga Opthalmology
• Leave a reponse

A small percentage of children who are seen for increased cup–disc ratio will develop glaucoma, most commonly in the first months following presentation. Source: AAO

• Posted on: Mar 27 2023
• By: Saratoga Opthalmology
• Leave a reponse

A meta-analysis suggests that visual and anatomic outcomes after macular detachment surgery worsen the longer a patient experiences symptoms before seeking treatment. Source: AAO

• Posted on: Mar 24 2023
• By: Saratoga Opthalmology
• Leave a reponse

Wavefront-guided photorefractive keratectomy (PRK) was found not only to be a safe and successful treatment option but also one that left 99% of patients highly satisfied. Source: AAO

• Posted on: Mar 23 2023
• By: Saratoga Opthalmology
• Leave a reponse

In comparison with spectral-domain OCT (SD-OCT), Pentacam OCT appears to underestimate corneal thickness following customized corneal crosslinking to treat keratoconus. Source: AAO

• Posted on: Mar 22 2023
• By: Saratoga Opthalmology
• Leave a reponse

Centrally located corneal scarring due to herpes simplex virus appears to significantly decrease corneal nerve regenerative abilities in comparison to scarring located more peripherally. Source: AAO

• Posted on: Mar 21 2023
• By: Saratoga Opthalmology
• Leave a reponse

The University of Edinburgh is awarding 12 scholarships in their Master of Surgery in Clinical Ophthalmology program through the support of The David and Molly Pyott Foundation. Source: AAO

• Posted on: Mar 21 2023
• By: Saratoga Opthalmology
• Leave a reponse

Congenital nasolacrimal duct obstruction (CNLDO) is often seen in children with Down syndrome, but is harder to treat in this patient population. Source: AAO

• Posted on: Mar 20 2023
• By: Saratoga Opthalmology
• Leave a reponse

Investigators evaluated whether taking proton pump inhibitors and histamine-2 blockers is a potential risk factor for ocular toxoplasmosis development. Source: AAO

• Posted on: Mar 17 2023
• By: Saratoga Opthalmology
• Leave a reponse

A camera attachment allows visually impaired people to take photos and videos, Medicare reimbursements don’t cover the costs of complex cataract surgeries, and substance use before age 21 may cause later visual impairment. Source: AAO

• Posted on: Mar 17 2023
• By: Saratoga Opthalmology
• Leave a reponse